JGL today

The basis of JGL growth and development have always been, and continue to be, its employees - their knowledge, skills and values, teamwork, excellence and closeness.

Of almost 530 employees, 63% have a university degree and their average age is 38, what creates a highly dynamic, modern and entrepreneurial company environment. Our objective is continuous development of the management and leadership skills on all company levels, and providing everyone with the opportunity for personal growth, with the goal of preserving a motivating teamwork environment.

Our fundamental activities are R&D, registration, production, marketing and sales of generic prescription drugs, non-prescription drugs, drugs based on natural substances, dietary products, medical products and dermatological cosmetics.

JGL's wide range of products in a number of pharmaceutical forms is primarily a result of company development, as well as of partnerships with other pharmaceutical companies such as Bristol-Myers Squibb, Krka, Christian Hansen and Zetta Pharmaceutici.

Today the JGL portfolio encompasses more than 300 products and in addition to its domestic market, it operates on the various markets in SEE, CIS (The Commonwealth of Independent States) and on the Far East, while negotiations regarding markets in Brazil and Great Britain are currently under way.

We are focused on the development of generic drugs with an added value in what we consider to be key therapeutic areas (drugs affecting the cardiovascular system, drugs affecting the blood and hematopoietic organs, drugs affecting the digestive system and the exchange of substances, as well as drugs affecting senses), which are marketed under brand names. The wide range of our generic drugs, in a number of pharmaceutical forms and doses, allows doctors to choose the best drug for their patients.

The present market positions were acquired through systematic investments into employee knowledge and development, into the development and launch of new products, and by investments into modern technology and new markets. The average growth rate over the past 20 years was 23%, placing JGL among the fastest growing and most stable Croatian companies.

Investments into production capacities are continuous, with the objective of maintaining and enhancing the accomplished high production standards. We manufacture solid oral forms - capsules and tablets; semi-solid forms - ointments, creams and gels; solutions - syrups, herbal drops, dermatological solutions and tea. We specialize in the production of sterile solutions (eye drops, sprays and nose drops).

We implement modern quality management principles in all production processes. Our primary standard is GMP (Good Manufacturing Practise), in addition to other standards, such as the ISO 9001 (Quality management systems), the ISO 13485 (Medical devices - quality management systems) and the ISO 22000 (Food safety management systems) certificate, based on the core HACCP principles. Today the company is certified in accordance with the EC GMP and the ISO (International Organization for Standardization) standards, while the procedure for obtaining the Canadian GMP is under way."

Always aware and determined that quality is imperative, in addition to constant improvements of the production process, new and innovative technological solutions are sought out, while professional, honest and personalized services are offered on the market and to our customers. We want doctors to have the option of choosing the best solution to treat their patients, from the selection of our brand-name generic drugs, for consumers to recognize the value of our non-prescription drugs, products from the Aqua Maris product range and other products, and for our partners to see us as a stable and flexible partner, recognizing their specific needs and offering customised solutions.

Today JGL proudly ranks third within the national pharmaceutical industry, with revenue amounting to around HRK 700 million in 2011. In company ratings within the Croatian economy, JGL has been among the 200 most successful companies in Croatia. In 2009, we won a medal for ranking 105th, based on created value, which is a shift up of nine places in comparison to the previous year. Export results were also ranked high, where JGL holds the 44th place.

Close relations with customers, along with the globalisation of our operation, are fundamental strategic indicator of JLG. We want to be a reliable and long-standing partner to doctors, pharmacies and everyone caring about health!